NDC 67877-882 – Rivaroxaban

Rivaroxaban 155 mg/1 · Granule, For Suspension · Oral

Human Prescription Drug

Product NDC67877-882

Product details

Brand name
Rivaroxaban
Generic name
Rivaroxaban
Labeler
Ascend Laboratories, LLC
Dosage form
Granule, For Suspension
Route
Oral
Marketing category
ANDA · ANDA218502
Marketed since
July 7, 2025
Listing expires
December 31, 2026
Pharmacologic class
Factor Xa Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Rivaroxaban →

Package NDC codes (1)

Package NDCDescriptionSince
67877-882-711 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLEJul 7, 2025

Other Rivaroxaban products